Antineoplastic agent busulfan regulates a network of genes related to coagulation and fibrinolysis.

Purpose: Hepatic veno-occlusive disease (HVOD) is one of the major complications following hematopoietic stem cell transplantation (HSCT). Although high-dose busulfan is associated with the development of HVOD, the underlying molecular mechanisms are still unknown. Methods: Transcriptional gene regu...

Descripción completa

Detalles Bibliográficos
Publicado en:European Journal of Clinical Pharmacology Vol. 68; no. 6; pp. 923 - 936
Autores principales: Reimer, Janka, Bien, Sandra, Ameling, Sabine, Hammer, Elke, Völker, Uwe, Hempel, Georg, Boos, Joachim, Kroemer, Heyo, Ritter, Christoph
Formato: research tables/charts Journal Article
Publicado: Springer Nature Jun2012
Acceso en línea:Ver este registro en EBSCOhost